Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MMM | Common Stock | Options Exercise | $380K | +2.85K | +1744.65% | $133.53 | 3.01K | Nov 29, 2024 | Direct | |
transaction | MMM | Common Stock | Tax liability | -$146K | -1.1K | -36.4% | $133.53 | 1.91K | Nov 29, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MMM | Restricted Stock Units | Options Exercise | $0 | -2.85K | -33.33% | $0.00 | 5.69K | Nov 29, 2024 | Common Stock | 2.85K | Direct | F2, F3, F4 |
Id | Content |
---|---|
F1 | Includes shares acquired under 3M's General Employee Stock Purchase Plan. |
F2 | Each restricted stock unit represents a contingent right to receive one share of 3M common stock. |
F3 | The restricted stock units vest in three equal annual installments beginning December 1, 2024. |
F4 | The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024. |